Linda Nussbaum is the Founding and Senior Partner at Nussbaum Law Group, P.C., where she specializes in plaintiff’s antitrust litigation in both class and individual actions.
Nussbaum recently conducted a five-week jury trial on behalf of Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals in Boston before Justice Saris resulting in a RICO verdict against Pfizer of $47 million before trebling. She was selected as Litigator of the Week by the AmLaw Litigation Daily on April 2, 2010 for her role in the trial.
Nussbaum has lectured and written extensively about various aspects of antitrust law. Her articles include: “The Evolving Challenges of Class Certification” presented at the American Antitrust Institute’s Third Annual Symposium on Private Antitrust Enforcement on December 8, 2009; “Daubert 15 Years Later: How Have Economists Fared?” presented at the ABA Section of Antitrust Law Spring Meeting in March 2009; and “The Hatch-Waxman Act 25 Years Later: Successes, Failures and Prescriptions for the Future,” presented at a panel on “Lawyers, Drugs and Money, a Prescription for Antitrust Enforcement in the Pharmaceutical Industry” at the University of San Francisco School of Law Antitrust Symposium on September 25, 2009.
Other recent presentations by Nussbaum include panel discussions at the 57th Annual Antitrust Law Spring Meeting of the ABA in March 2009; the ABA Section of Antitrust Law Brown Bag Program in April 2009; the 56th Annual Antitrust Law Spring Meeting of the ABA in March 2008; the New York State Bar Association’s 2007 and 2008 Annual Meetings; the 55th Annual Antitrust Law Spring Meeting of the ABA in Washington, D.C. in April 2007; and the ABA Antitrust Litigation Course in Philadelphia in October, 2007.
Nussbaum has served as sole or co-lead counsel in many significant antitrust class actions which have resulted in substantial recoveries, many in the realm of hundreds of millions of dollars. See In re Microcrystalline Cellulose Antitrust Litigation (E.D.Pa. Master File No. 01-CV-111 (O’Neill, J.) (co-lead counsel); Oncology & Radiation Associates, P.A. v. Bristol Myers Squibb Co., et al. (Taxol Antitrust Litigation) (D.D.C. Case No. 01-cv-02313) (sole lead counsel); North Shore Hematology-Oncology Associates, P.C. v. Bristol-Meyers Squibb Co. (Platinol Antitrust Litigation) (D.D.C. Case No. 04-cv-00248) (sole lead counsel); In re Children’s Ibuprofen Oral Suspension Antitrust Litigation, (D.D.C. Case No. 04-mc-0535) (sole lead counsel); In re Relafen Antitrust Litigation (D.Mass. Master File No. 01-cv-12239) (co-lead counsel); In re Plastics Additives Antitrust Litigation (E.D.Pa. Case No. 03-cv-2038) (co-lead counsel); In re Remeron Antitrust Litigation (D.N.J. Master Docket No. 03-cv-00085) (co-lead counsel); Meijer, et al. v. Warner Chilcott Holdings Company, III, Ltd., et al. (Ovcon Antitrust Litigation), (D.D.C. Case No. 05-cv-2195 (CKK) (lead counsel committee); and In re Lorazepam & Clorazepate Antitrust Litigation (D.D.C. Case No. 99-cv-00276) (co-lead counsel), where Chief Judge Hogan commented, “Obviously, the skill of the attorneys, and I’m not going to spend the time reviewing it, I’m familiar with counsel, and they, as I said, are among the best antitrust litigators in the country.”
Nussbaum is presently serving in lead counsel positions in: In re Puerto Rican Cabotage Antitrust Litigation, Case No. 08-md-1960 (DRD) (D.P.R.); In re DDAVP Direct Purchaser Antitrust Litigation, Case No. 1:05-cv-2237 (S.D.N.Y.); In re Fasteners Antitrust Litigation, Case No. 2:08-md-01912 (E.D.Pa.); In re Wellbutrin XL Antitrust Litigation, Case No. 08-cv-2431 (MAM) (E.D.Pa.); Meijer, Inc., et al. v. Astrazeneca Pharmaceuticals Lp, et al (Torprol Antitrust Litigation), Case No.06-cv-52 (GMS) (D. Del); and Meijer, Inc., et al. v. Abbott Laboratories (Norvir Antitrust Litigation), Case No. 3:07cv5985 (CW) (N.D.Ca.).
In addition, she represents large corporate entities in individual actions in In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, Case No. 1:05-md- 1720 (JG) (JO) (E.D.N.Y.); In re Neurontin Marketing and Sales Practices Litigation, Master File No. 04-10981 (PBS) MDL Docket No. 1629 (D. Mass.); In re Chocolate Confectionary Antitrust Litigation, Case No. 1:08-md-1935 (CCC) (M.D.Pa.); and CVS Pharmacy v. American Express Travel Related Services, et al., Case No. 08-cv-2316 (NGG) (E.D.N.Y.).